-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Gain Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
- Gain Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.49M, a 4.93% increase year-over-year.
- Gain Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$21.4M, a 3.83% increase year-over-year.
- Gain Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$22.3M, a 26.6% decline from 2022.
- Gain Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$17.6M, a 26.6% decline from 2021.
- Gain Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$13.9M, a 288% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)